Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression.

The insulin receptor (IR) and the insulin-like growth factor-1 receptor (IGF-1R) are members of the same subfamily of receptor tyrosine kinases. The two receptors phosphorylate many of the same substrates and activate the same signaling modules, including the mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3' kinase (PI3K) signaling pathways. Although the IR and IGF-1R share some redundant functions in metabolism, cell growth, differentiation, and apoptosis, they also exhibit distinct physiological roles. Some of these may be due to differences in tissue distribution, receptor structure, formation of hybrid receptors, or mechanisms of ligand binding. However, the divergent effects of insulin and IGF-1 also may be explained by specificity in the intracellular signals generated by insulin and IGF-1. In particular, the IR and IGF-1R are capable of triggering their own biological responses by using specific or preferential substrates, molecular adapters, or signaling pathways. In a recent study, we used cDNA microarray analysis to identify genes differentially regulated by insulin and IGF-1. Mouse NIH-3T3 fibroblasts expressing either the wild-type human IGF-1R or IR were stimulated with either IGF-1 or insulin, respectively. We identified 39 genes differentially regulated by insulin and IGF-1. Most of these genes had not been reported previously to be responsive to insulin or IGF-1. The genes induced by IGF-1 generally were involved in mitogenesis or differentiation, while the genes found to be induced by insulin did not conform to any particular category. In a separate study, immortalized breast epithelial cells were stimulated with IGF-1 and a cDNA microarray analysis was used to generate a profile of IGF-1-regulated genes. A number of genes known to be involved in angiogenesis were found to be regulated by IGF-1. These results strongly suggest that this technology may be extremely useful in identifying groups of genes that are specifically regulated by different ligands and their activated receptors.

[1]  R. O'Connor,et al.  RACK1 Is an Insulin-like Growth Factor 1 (IGF-1) Receptor-interacting Protein That Can Regulate IGF-1-mediated Akt Activation and Protection from Cell Death* , 2002, The Journal of Biological Chemistry.

[2]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.

[3]  Weiqun Li,et al.  RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix , 2002, Molecular and Cellular Biology.

[4]  J. Girard,et al.  Inhibition of Insulin Receptor Catalytic Activity by the Molecular Adapter Grb14* , 2002, The Journal of Biological Chemistry.

[5]  Y. Kido,et al.  Distinct and overlapping functions of insulin and IGF-I receptors. , 2001, Endocrine reviews.

[6]  D. Leroith,et al.  Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysis. , 2001, Endocrinology.

[7]  E. Walum,et al.  Insulin-like growth factor type 1 upregulates uncoupling protein 3. , 2001, Biochemical and biophysical research communications.

[8]  W. Miller,et al.  Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. , 2001, The Journal of endocrinology.

[9]  J. Camonis,et al.  A PDZ Domain Protein Interacts with the C-terminal Tail of the Insulin-like Growth Factor-1 Receptor but Not with the Insulin Receptor* , 2001, The Journal of Biological Chemistry.

[10]  B. Ursø,et al.  Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. , 2001, Biochemical Society transactions.

[11]  D. Leroith,et al.  Insulin-like Growth Factor 1 (IGF-1)-induced Twist Expression Is Involved in the Anti-apoptotic Effects of the IGF-1 Receptor* , 2001, The Journal of Biological Chemistry.

[12]  H. Lai,et al.  Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes , 2001, Circulation research.

[13]  P. Vollenweider,et al.  Insulin and Insulin-like Growth Factor I Receptors Utilize Different G Protein Signaling Components* , 2001, The Journal of Biological Chemistry.

[14]  B. Ursø,et al.  Comparison of anti-apoptotic signalling by the insulin receptor and IGF-I receptor in preadipocytes and adipocytes. , 2001, Cellular signalling.

[15]  T. Kuroki,et al.  PKCdelta activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes. , 2001, Diabetes.

[16]  L Rensing,et al.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review , 2000, Cell proliferation.

[17]  E. Van Obberghen,et al.  Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[18]  T. Tennenbaum,et al.  Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. , 2000, The Journal of investigative dermatology.

[19]  M. N. Poy,et al.  The Differential Effects of pp120 (Ceacam 1) on the Mitogenic Action of Insulin and Insulin-Like Growth Factor 1 Are Regulated by the Nonconserved Tyrosine 1316 in the Insulin Receptor , 2000, Molecular and Cellular Biology.

[20]  C. Kahn,et al.  Gab-1-mediated IGF-1 Signaling in IRS-1-deficient 3T3 Fibroblasts* , 2000, The Journal of Biological Chemistry.

[21]  D. Accili,et al.  Differential regulation of gene expression by insulin and IGF‐1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR , 2000, The EMBO journal.

[22]  B. Ursø,et al.  Differences in Signaling Properties of the Cytoplasmic Domains of the Insulin Receptor and Insulin-like Growth Factor Receptor in 3T3-L1 Adipocytes* , 1999, The Journal of Biological Chemistry.

[23]  John W. Adams,et al.  G Alpha-q / 11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3 T 3L 1 Adipocytes , 1999 .

[24]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[25]  F. Folli,et al.  Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways , 1999, Hepatology.

[26]  Y. Kido,et al.  Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. , 1999, Biochemistry.

[27]  E. Van Obberghen,et al.  Identification of the Rat Adapter Grb14 as an Inhibitor of Insulin Actions* , 1998, The Journal of Biological Chemistry.

[28]  D. Accili,et al.  Evidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes* , 1998, The Journal of Biological Chemistry.

[29]  J. Slot,et al.  Characterization of Insulin Receptor Substrate 4 in Human Embryonic Kidney 293 Cells* , 1998, The Journal of Biological Chemistry.

[30]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[31]  B. R. Dey,et al.  14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. , 1997, The Biochemical journal.

[32]  S. O’Rahilly,et al.  Differential Signaling to Glycogen Synthesis by the Intracellular Domain of the Insulin versus the Insulin-like Growth Factor-1 Receptor , 1997, The Journal of Biological Chemistry.

[33]  D. Leroith,et al.  Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. , 1997, Biochemistry.

[34]  G. Sesti,et al.  Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues , 1997, Molecular and Cellular Endocrinology.

[35]  J. Ooi,et al.  The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. , 1997, The Journal of clinical investigation.

[36]  D. Le Roith,et al.  Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? , 1996, Cytokine & growth factor reviews.

[37]  M. White,et al.  The Fyn Tyrosine Kinase Binds Irs-1 and Forms a Distinct Signaling Complex during Insulin Stimulation (*) , 1996, The Journal of Biological Chemistry.

[38]  D. Leroith,et al.  The Proto-oncogene Product c-Crk Associates with Insulin Receptor Substrate-1 and 4PS , 1996, The Journal of Biological Chemistry.

[39]  C. Kahn,et al.  4PS/Insulin Receptor Substrate (IRS)-2 Is the Alternative Substrate of the Insulin Receptor in IRS-1-deficient Mice (*) , 1995, The Journal of Biological Chemistry.

[40]  J. Olefsky,et al.  Signal transduction pathways leading to insulin-induced early gene induction. , 1995, Biochemistry.

[41]  C. Kahn,et al.  Insulin action and the insulin signaling network. , 1995, Endocrine reviews.

[42]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[43]  Thomas,et al.  Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. , 1995, Cancer research.

[44]  C. Roberts,et al.  Mutation of a Conserved Amino Acid Residue (Tryptophan 1173) in the Tyrosine Kinase Domain of the IGF-I Receptor Abolishes Autophosphorylation but Does Not Eliminate Biologic Function (*) , 1995, The Journal of Biological Chemistry.

[45]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[46]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[47]  J. Zwiller,et al.  Insulin-like growth factor-I stimulates c-fos and c-jun transcription in PC12 cells , 1994, Molecular and Cellular Endocrinology.

[48]  W. Paul,et al.  Interleukin 4 receptor: signaling mechanisms. , 1994, Immunology today.

[49]  S. Shoelson,et al.  Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.

[50]  D. Perlmutter,et al.  Bile acid efflux mediated by the rat liver canalicular bile acid transport/ecto-ATPase protein requires serine 503 phosphorylation and is regulated by tyrosine 488 phosphorylation. , 1994, The Journal of biological chemistry.

[51]  M. White,et al.  The IRS-1 signaling system. , 1994, Trends in biochemical sciences.

[52]  E. Van Obberghen,et al.  Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor. , 1994, The Journal of biological chemistry.

[53]  D. Accili,et al.  Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: comparison of receptors expressed in CHO and NIH-3T3 cells. , 1993, Biochimica et biophysica acta.

[54]  M. White,et al.  Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Crews,et al.  Extracellular signals and reversible protein phosphorylation: What to Mek of it all , 1993, Cell.

[56]  J. Blenis,et al.  Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Ullrich,et al.  The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.

[58]  G. Lienhard,et al.  The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. , 1993, The Journal of biological chemistry.

[59]  C. Roberts,et al.  Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). , 1993, The Journal of biological chemistry.

[60]  B. Margolis,et al.  Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation. , 1992, The EMBO journal.

[61]  A. Ullrich,et al.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.

[62]  T. Pawson,et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.

[63]  S. Chiou,et al.  Insulin-like growth factor I stimulates transcription of the c-jun proto-oncogene in Balb/C 3T3 cells. , 1992, Biochemical and biophysical research communications.

[64]  A. Ullrich,et al.  Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. , 1991, The Journal of biological chemistry.

[65]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[66]  W. Rutter,et al.  The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.

[67]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[68]  P. Zelenka,et al.  Insulin-like growth factor I and insulin regulate delta-crystallin gene expression in developing lens. , 1989, The Journal of biological chemistry.

[69]  A. Ullrich,et al.  Differential signalling potential of insulin‐ and IGF‐1‐receptor cytoplasmic domains. , 1989, The EMBO journal.

[70]  A. Ullrich,et al.  Molecular analysis of signal transduction by growth factors. , 1988, Biochemistry.

[71]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[72]  P. Bushel,et al.  Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. , 2002, Neoplasia.

[73]  G. Shulman,et al.  Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904 , 1998 .

[74]  E. Olson,et al.  bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. , 1994, Genes & development.

[75]  C. Bonne,et al.  Insulin-like growth factor-1 (IGF-1) specifically binds to bovine lens epithelial cells and increases the number of fibronectin receptor sites. , 1994, Current eye research.